Flex sites in Tczew, Poland and Pelabuhan Tanjung Pelepas, Malaysia demonstrated continuous improvement culture and lean systems implementation to achieve manufacturing and operational excellence. The ...
Altimmune, Inc. shares surged nearly 30% after positive Phase 2 clinical study results for pemvidutide, a GLP-1/glucagon dual receptor agonist for obesity and MASH. Pemvidutide may compete with Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback